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Abstract 
The structure of the vanadium bromoperoxidase from the red algae Corallina 
pilulifera has been solved in the presence of the substrates, phenol red and 
phloroglucinol. The results obtained give  a putative location close to the active site of 
the enzyme. In addition bromide has been soaked into the crystals and has been 
shown to bind unambiguously within the active site using single anomalous 
dispersion. A mutant of the enzyme where arginine 397 has been changed to 
tryptophan, shows a different behaviour on bromide binding regarding the 
displacement of a specific leucine amino acid which is seen to move towards the 
incoming ion in the wild-type protein to produce a hydrophobic environment within 
the active site.  
These results have increased our understanding of the mechanism of the vanadium 
bromoperoxidases and have demonstrated that the substrate and bromide are 
specifically bound to the enzyme active site. 
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Introduction 
The vanadium bromoperoxidase enzymes has attracted much interest in recent years 
due to their applications in biocatalysis for the introduction of bromine groups to 
aromatic compounds many of which have anti-bacterial and anti-cancer properties. 
They have also fascinated inorganic chemists and biochemists with respect to their 
mechanistic details and dependence on vanadium for their activity. 
 The vanadium bromoperoxidase enzymes from two members of the red algal species, 
Corallina, have been previously studied in detail at a structural level [1,2]. These 
enzymes form a large dodecameric structure with 12 protein subunits each containing 
vanadium V which is essential for activity. The structure of C. officinalis vanadium 
haloperoxidase was solved to 2.3Å in 2000 by Isupov et al., [1] and showed a 595 
amino acid chain folded into a single α + β type domain. The structure does not 
contain any disulfide bridges as found in the related Ascophyllum bromoperoxidase 
[3].  There are twelve monomers, each consisting of 19 α-helices which are 6 to 26 
residues in length, eight 310 helices and 14 β-strands which are mainly involved in β-
hairpins. One surface of the monomer is flat and upon dimerisation this surface forms 
the central region resulting in two four-helical bundles at the centre of each dimer. 
The active site cleft uses amino acid residues from both monomers, with the residues 
of one predominantly being responsible for the bottom of the active site binding the 
vanadate, while the other constitutes the top region of the active site cleft . The dimers 
then interact to form the dodecamer with a 23 cubic point symmetry, which is 
approximately 150Å in diameter [1] (Figure 1). Two vanadate atoms are associated 
with each dimeric subunit and are co-ordinated in a trigonal bipyramidal geometry 
with hydroxide and His496 in axial positions and three non-protein (solvent) oxygen 
atoms in equatorial positions. The original structure, due to the availability of crystals 
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suitable for the X-ray structural solution, was solved with phosphate in place of the 
vanadate in the active site of the enzyme this was due to the high concentration of 
phosphate used in the crystallisation conditions. Phosphate prevents vanadate binding 
and it has been by others in the study of a fungal vanadium chloroperoxidase if 
phosphate binds to the active site phosphatase activity can be observed [4,5]. The 
structure of the vanadate bound form of the Corallina vanadium bromoperoxidase has 
now been solved using a different crystal form of the enzyme grown from 
polyethylene glycol in the presence of potassium bromide (KBr) [2]. The structure of 
the enzyme’s active site does not show any significant difference to that of the 
phosphate-complexed structure, other than the coordination of vanadate with His553. 
The Corallina vanadium bromoperoxidase is found to be stabilised by calcium and 
vanadium bound to the enzyme. One divalent cation (Ca
2+
 or Mg
2+
) is observed per 
monomer from the crystallographic analysis. A systematic study regarding the role of 
metal ions on the stability of the enzyme has been carried out [6]. The structural 
analysis of the C. pilulifera recombinant enzyme over-expressed in yeast revealed that 
it contains one calcium atom per subunit which is found in the loop between the 
amino acid residues at 359 and 366, and that it is coordinated by the main chain 
oxygen atoms of Phe359, Gln361 and Gln368 and the carboxyl groups of Asp363 and 
Asp366 and a molecule of water [2].  
Crystallographic studies have provided some information to help understand the 
mechanism of the Corallina vanadium dependent haloperoxidases. The nature of the 
brominating agent for this enzyme has been described as a ‘Br+-like intermediate’ 
being either a free halogenating agent such as HOBr, Br2, or Br3
-
 or an Enz-Br or 
Venz-OBr species [7]. EXAS studies [8] have shown that the bromide binds within the 
active site in proximity to the vanadate centre. This would permit the bromide to 
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directly attack the peroxyvanadate centre in the first step of the halide oxidation in the 
enzyme mechanism. 
With knowledge of the overall structure of the dodecameric Corallina bromoperoxidase 
enzyme an active mutant dimeric enzyme has been made where a substantial portion of 
the N-terminus of each monomer has been deleted
 
[9]. This enzyme can be over-
expressed in Escherichia coli in the soluble fraction whereas the dodecameric form is 
only overexpressed as inclusion bodies. However it has also been possible to refold the 
recombinant native form of the enzyme  in vitro to produce an active dodecameric form 
that resembles the wild type enzyme isolated from the Corallina species
 
[10]. 
The structural information previously carried out has allowed an understanding of the 
halide specificity of the Corallina bromoperoxidase and a mutant enzyme has been 
constructed of the C. pilulifera bromoperoxidase which also has chloroperoxidase 
activity
 
[11]. The study presented in this paper presents the structural determination of 
this mutant enzyme.  
The structure of wild-type recombinant C. pilulifera bromoperoxidase has been solved in 
the presence of the substrates, phenol red and phloroglucinol. In addition bromide has 
been soaked into the wild-type and mutant enzyme crystals which has allowed its 
location within the active site of the enzymes. 
2. Experimental 
2.1-Purification of Recombinant and Mutant Enzymes-The enzymes were cloned and 
over-expressed and assayed for activity as previously described [2, 6, 11,12]. 
2.2- Crystallisation-The crystallisation trials with the recombinant wild-type enzyme 
were set up using both hanging and sitting drop vapour diffusion techniques based on 
previously reported conditions [13,14]. Two crystal forms were obtained, one using 
ammonium phosphate as precipitant, an hexagonal form,  and the second a cubic  
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vanadium bound called form 2. The best crystals of form 2 which were only produced 
with the wild-type enzyme were using an initial protein of 18mg/ml in 50mM Tris-
H2SO4, 0.4M KBr, 1mM Na3VO4, 20% (w/v) polyethylene glycol 6000. The wild-type 
enzyme was also crystallised in form 1 as previously described [14]. The mutant enzyme 
could only be crystallised in form 1 under conditions of 100mM Tris-HBr pH 7.4, 1.3M 
ammonium phosphate giving a final pH of 4.0. A cryoprotectant at 100mM Tris- H2SO4, 
pH 8.5, 1.6M ammonium phosphate, 25% (v/v) glycerol was used for data collection. 
For the wild-type enzyme crystals grown from polyethylene glycol 6000 a mother liquor 
substituting the precipitant with 25% polyethylene glycol 400 and 25% polyethylene 
glycol 6000 was used to allow cryo-cooling without formation of ice. The crystal 
soaking experiments were carried out with a 5% addition of phenol red and 
phoroglucinol to the relevant cryoprotectant. The bromide soaks were carried out by 
making the cryoprotectant 50mM potassium bromide. Soaks were carried out for a 
variety of times from 30seconds to several minutes and monitored by visual examination 
of the crystals for cracking etc.before freezing for data collection. 
2.3- Data Collection- 
All data was collected under cryocooled conditions at the Hamburg Synchrotron 
Facilities, DESY, on Station BW7a. The beamline wavelength was adjusted to 0.9076Å, 
close to the absorption edge of the element bromine (0.9202Å) in order to use the 
anomalous dispersion to locate the potential bromine ions in the structure. The 
crystallographic data was processed and scaled using the HKL package [15]. Molecular 
Replacement procedures were carried out using the program AmoRe from the CCP4 
package [16]. The refinement procedure was carried out using REFMAC [17] with 
graphical support of the programs O [18] and COOT [19]. The analysis of the anomalous 
signal was performed using the programs fft and peakmax CCP4 [20]. Libraries with the 
 7 
chemical and geometric descriptors for chemically modified residues of the mutant 
protein were created using the program Sketcher and minimisation calculations 
performed with the program REFMAC, CCP4i graphical interface. The molecules of 
water within the structures were located and analysed with the program Woda 
(Teplyakov, personal communication). Analysis of the quality of the data and the 
structure solutions were carried out using the programs SFCHECK [21] and 
PROCHECK [22]. 
3. Results 
We have used Corallina vanadium haloperoxidase enzymes and a selected mutant, 
arginine397tryptophan that have been crystallised and subjected to substrate soaking 
experiments with phenol red, phoroglucinol and potassium bromide.  The substrate 
binding sites have been proposed to bind to a hydrophobic area in the active site 
channel of the enzyme.  The level of occupancy of the substrates does not allow 
detailed interactions to be seen.  
The addition of bromide to the crystals has produced unambiguous evidence for the 
binding of the halogen in the active site of the enzyme. The analysis of the anomalous 
signal has allowed the location of the  bromide in front of the arginine 397 residue in the 
wild-type enzyme cubic crystal form. The bromide is positioned within hydrogen 
bonding distance (2.8 -3.1 Å) between the vanadate ion and the arginine residue as 
shown in Figure 2 in both cartoon mode and with the electron density. There was also an 
anomalous scatterer located on the solvent exposed surface of the enzyme within 
covalent bonding distance to two tyrosine residues, Tyr186 and Tyr43. The bromination 
which is weak occurs on the (o-) position to the hyroxyl group and the residue appears to 
be mono-halogenated. It was also possible to locate the binding of bromide in the mutant 
enzyme hexagonal crystal although the position of the halogen is slightly different. As a 
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result of the absence of Arg397 the bromide is missing the hydrogen-binding interaction 
that held it in the active site of the wild-type enzyme. Instead it is located very close (3.0 
Å) to one of the phosphate oxygen atoms and in front of the newly introduced tryptophan 
residue. The difference between the two halogen positions is 2.5 Å. The bromination of 
the tyrosine residues described above is also observed for the mutant enzyme.  
Examination of the electron density after refinement of the structures results in a 
significant change of position of Leu337 in the wild-type enzyme towards the inner 
active site. This change suggests a relation of this movement with the presence of the 
halogen in the active site. This was not observed with the mutant enzyme (Figure 3). An 
additional change on bromide binding was the rotation by 25
o
 of a phenylalanine residue, 
Phe373, which is between the two monomers that make up the catalytic dimer. 
 In the non-halide bound structure the position in which the halogen and the Leu337 
side chain are located is occupied by one molecule of water in the equivalent position. 
When the halide is bound it appears that there is a formation of a hydrophobic pocket 
accompanied by a reduction in the size of the entrance to the entrance of the active 
site as shown in Figure 4. This eliminated water from the active site providing a 
hydrophobic environment for the reaction to occur. The crystal data sets of these 
halide complexes have been collected to a resolution of 1.78-2.5Ǻ. and the statistics 
of the data are given in Table 1 and 2. The structural information will be deposited in 
the PDB with codes (XXX and XXX). 
 
4. Discussion 
For many years it had been questioned as to whether the haloperoxidases bind their 
substrates, or whether they catalysed only the formation of the brominating agent and 
allowed the reaction to occur non-specifically. It has been demonstrated for the 
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bromoperoxidase from A. nodosum that there is a competition between indole and 
phenol red bromination [23]. In addition this group also demonstrated that the indole 
was binding to the active site as evidenced by fluorescence quenching. Furthermore, 
the same enzyme will catalyse a regiospecific indole bromination [24].  These results 
again are direct evidence that the reaction is occurring within the enzyme catalytic site. 
We have used Corallina vanadium haloperoxidase enzymes and a selected mutant, 
arginine397tryptophan that have been crystallised and subjected to substrate soaking 
experiments with phenol red and  phoroglucinol. These substrate binding sites have 
been located to a hydrophobic area in the active site channel of the enzyme. The 
Corallina bromoperoxidase enzyme shows a remarkable electronegative surface with 
the exception of the depth of the active site of each monomer where it exhibits a 
strong electropositive potential. Other slightly electropositive areas observed in the 
figure are burioed when the dimers adopt their dedodecameric arrangement. This 
difference in electrostatic potential allows the substrates to directly locate the active 
site of the enzyme. The upper part of active site channel of the enzyme is lined by 
hydrophobic residues on one side and hydrophilic on the other side. It has previously 
been proposed [3] that this could be involved in binding of organic substrates. It is on 
this basis that a putative substrate binding site has been proposed from the limited 
data obtained in this study. 
In addition crystallographic studies on the native and mutant protein have also been 
carried out by both co-crystallisation and soaking experiments with potassium 
bromide. This has shown that there is a specific halogen-binding site involving 
Arg397 in the enzyme and that there is involvement of the surrounding amino acids. 
All of the data sets in which halogen has been introduced show a consistent 
anomalous peak at approximately 3.6Ǻ from the vanadate (01), which is consistent 
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with a previous proposal [8]. The halogen atom appears to be bound to one of the 
terminal nitrogen atoms of Arg397 at a distance of 3 Ǻ. The remaining residues in the 
environment of the bromide ion are mainly hydrophobic that is a common feature of 
halogen binding to proteins [25]. The presence of bromide in the active site is 
associated with the displacement of Leu337 to form the hydrophobic pocket. This 
movement has not previously been observed. The environment of the active site could 
further change upon binding of peroxide but as yet no peroxo-complex has been 
crystallised. 
The activation of the Corallina bromoperoxidase enzyme towards the vanadate and 
the formation of the peroxovanadate intermediate is carried through different finely 
tuned mechanisms. The binding histidine residue His553 has strong several strong 
interactions via one of the nitrogen atoms of the imidazole ring which converts the 
remaining nitrogen into a highly reactive position and possibly changing the pKa of 
this residue. The vanadate ion is held in co-ordinating distance of this histidine by 
several hydrogen bonding interactions with the surrounding amino acids. Of these 
interactions the strongest is between Lys400 (2.4 Ǻ), followed by vanadate (03) to 
Ser485 (2.7 Ǻ). Lys400 together with Arg547 and Arg408 establish a protonated 
network around the vanadate ion [26]. These residues displace the charge on the 
vanadate ion, elongating the bonding distances between the equatorial oxygens and 
the vanadate and activating the ion towards attack by the hydrogen peroxide. The 
interaction and the role of His487 is relatively weak in bromination [26] 
The studies described in this paper have lead to an increased understanding of the 
structure of these bromoperoxidase enzymes and the role of the vanadium in the 
mechanism which is essential for this enzymatic bromination reaction. 
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   Wild-Type form 1          Wild-Type form 2        Mutant form 1 
Space group P63 P 21 3 P63 
Unit cell a/b/c Å 184.01, 184.01,177.93 199.60, 199.60,199.60 182.48, 182.48, 177.59 
Resolution range (Å) 15.00-2.38 14.92-2.15 29.87-1.78 
No. measured reflections 116933 141422 307595 
No. unique reflections 116933 141422 307595 
Completeness  86.0% 99.2% 96.3% 
Final Rcryst 0.223 0.152 0.163 
Rfree 0.28 0.22 0.19 
Average B-factor 
(protein) (Å
2
) 
33.1 27.1 
22.2 
Average B-factor 
(solvent) (Å
2
) 
  
 
Rms deviation from 
ideality 
  
 
Bond lengths (Å)    
Bond angles (°)    
 
Table 1 
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Figure Legends 
Figure 1 
The dodecameric structure of the Corallina vanadium bromoperoxidase. Each subunit 
is shown in a different colour. 
 
Figure 2 
The location of the bromide in the wild-type Corallina vanadium bromoperoxidase 
from the data set of crystals of form 2 in the presence of KBr and vanadate. The 
bromide is shown as a cyan sphere bound between the vanadate and residue Arg397 
at an H-bonding distance of 2.8-3.1Å. in cartoon mode. Both subunits are needed to 
create the active site pocket. Figure created with PYMOL [27]. 
 
Figure 3 
A figure showing the superimposition of the active site residues of the wild-type 
Corallina vanadium bromoperoxidase crystal form 2,  bromide bound (green 
backbone) and wild-type Corallina vanadium bromoperoxidase crystal form 1, non-
bound (yellow backbone) structures. The displacement of Leu 337  and Phe373 is 
indicated with arrows. The figure is prepared with the program COOT [19]. 
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Figure 4 
The electron density for the phosphate ion, His553, Trp397 and Leu337 (pink) 
pointing away from the active site in the mutant Arg398Trp Corallina vanadium 
bromoperoxidase  enzyme. The bromide ion is shown as a purple sphere and the Cα 
backbone in green ribbon.  The maps are drawn at one sigma (2Fo-Fc) and the 
positive difference map (in blue) at three sigma (Fo-Fc). The figure was prepared 
with the program BOBSCRIPT [28]. 
 
 
Figure 5 
A surface representation of the active site of the wild-type Corallina vanadium 
bromoperoxidase in the absence (above) and presence (below) of the halogen (cyan 
sphere)  showing the reduction in entrance of the active site between the crystal form 
one and the crystal form 2, vanadate, bromide bound structures. The green surface and 
side chains represent hydrophobic residues and the yellow non-hydrophobic residues. 
The surface was calculated with the MSMS package [29] and rendered with 
CHIMERA [30].
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